S. Bartholomeus

Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.

C. Focan, S. M. Steinberg, M Blichert-Toft et al. · PubMed · 1998 · 2.2K citations

Medicine, Oncology, Pharmacotherapy +5

Phase I safety and pharmacokinetics of BAY 43-9006 administered for 21 days on/7 days off in patients with advanced, refractory solid tumours

Ahmad Awada, Alain Hendlisz, Thierry Gil et al. · British Journal of Cancer · 2005 · 338 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +14

A phase I, dose-escalation study of the novel Polo-like kinase inhibitor volasertib (BI 6727) in patients with advanced solid tumours

Patrick Schöffski, Ahmad Awada, Herlinde Dumez et al. · European Journal of Cancer · 2011 · 165 citations

Medicine, Oncology, Pharmacology +14

Phase III Trial Comparing Two Dose Levels of Epirubicin Combined With Cyclophosphamide With Cyclophosphamide, Methotrexate, and Fluorouracil in Node-Positive Breast Cancer

Martine Piccart, Angelo Di Leo, M. Beauduin et al. · Journal of Clinical Oncology · 2001 · 163 citations

Medicine, Oncology, Pharmacotherapy +11

An EORTC pilot study of filgrastim (recombinant human granulocyte colony stimulating factor) as support to a high dose-intensive epiadriamycin-cyclophosphamide regimen in chemotherapy-naive patients with locally advanced or metastatic breast cancer

Martine Piccart, P.F. Bruning, J. Wildiers et al. · Annals of Oncology · 1995 · 32 citations

Medicine, Oncology, Pharmacology +17